Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.97 +0.16 (+0.62%)
Streaming Delayed Price Updated: 12:29 PM EDT, May 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
40 41 Next >
News headline image
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:PFE),(NYSE:NVO),(NYSE:HIMS),(NYSE:LLY) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
Next-generation wellness platforms targeting longevity, metabolism, and performance continue gaining momentum in one of healthcare’s fastest-growing sectors 
From MarketNewsUpdates.com
Via GlobeNewswire
News headline image
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)
From Arvinas Inc.
Via GlobeNewswire
BioMedNewsBreaks — SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Advances Next-Generation GLP-1 Candidate as Obesity Drug Market Expands Rapidly
Via Investor Brand Network
News headline image
The Next Generation of the GLP-1 Revolution Is Already Underway
From BioMedWire
Via GlobeNewswire
What Are Horizontal Mergers and Acquisitions?
Via BusinesNews Wire
Topics Economy
News headline image
Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance
From Pfizer Inc.
Via Business Wire
News headline image
Poets&Quants™ Names Best & Brightest MBAs of 2026
May 5, 2026 -- Annual feature celebrates graduating business students for campus impact and professional achievement 
Via 24-7 Press Release
News headline image
Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Reaches Three Settlement Agreements for VYNDAMAX
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Declares Second-Quarter 2026 Dividend
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026
From Pfizer Inc.
Via Business Wire
News headline image
Dividend Stock Guru Unveils High Yield Dividend Stock Research Reports
Via PRLog
News headline image
Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders
From Pfizer Inc.
Via Business Wire
News headline image
Telix Strengthens Board with Additional Director Appointments
From Telix Pharmaceuticals Limited
Via GlobeNewswire
News headline image
OS Therapies Appoints Craig Eagle, MD as Strategic Advisor
Senior leadership roles at Guardant Health, Genentech and PfizerRegulatory, clinical and commercial expertise in therapeutics and biomarkersWill assist with osteosarcoma... 
Via Newsfile
News headline image
AI-Enhanced Robotics in Pharma Manufacturing Signals Major Efficiency, Margin Expansion Opportunities
From AINewsWire
Via GlobeNewswire
News headline image
Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC
From Pfizer Inc.
Via Business Wire
News headline image
TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
From Pfizer Inc.
Via Business Wire
News headline image
Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer
From Pfizer Inc.
Via Business Wire
News headline image
Rushing Headlong: Health IT's Legacy and the Road to Responsible AI Named 2025 Foreword INDIES Book of the Year Awards Finalist
Via PRLog
Topics Artificial Intelligence
News headline image
Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis
From Pfizer Inc.
Via Business Wire
TechMediaBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Appoints Bat-Sheva Noy as Vice President of Global Sales
Via Investor Brand Network
News headline image
PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
From Pfizer Inc.
Via Business Wire
News headline image
U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer
From Pfizer Inc.
Via Business Wire
TinyGemsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Dr. Freda Lewis-Hall to Board and Scientific Advisory Committee Chair
Via Investor Brand Network
News headline image
Next-Generation Psychiatric Therapies Target Massive $40B+ Market Opportunity
EQNX::TICKER_START (NASDAQ:HELP),(CBOE:HELP),(NYSE:TAK),(NASDAQ:CMPS),(NYSE:PFE),(NYSE:BMY) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Helus Pharma Appoints Former Pfizer Chief Medical Officer Dr. Freda Lewis-Hall to Board of Directors & Chair of the Scientific Advisory Committee
In this role, Dr. Lewis-Hall will guide clinical development strategy, regulatory engagement, and translational rigor across Helus’ novel serotonergic agonist (“NSA”) portfolio This news release... 
Via FinancialNewsMedia
< Previous 1 2 3 4 5 6 7 8 9
...
40 41 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.